Saxenda® (Liraglutide) is a clinically approved injectable treatment used for chronic weight management in adults with obesity or overweight conditions.
As a GLP-1 receptor agonist, it works by targeting appetite control centers in the brain, helping patients:
-
Reduce hunger and cravings
-
Improve portion control
-
Achieve gradual, sustainable weight loss
-
Support metabolic health
Saxenda® is administered once daily and is widely used in structured weight loss programs across Europe and international medical markets.
Reviews
There are no reviews yet.